Disclosure: We may earn a commission if you buy through links on this page — at no extra cost to you. Learn more.
Statements on this site have not been evaluated by the Food and Drug Administration.
Products and information are not intended to diagnose, treat, cure, or prevent any disease. Learn More
Products and information are not intended to diagnose, treat, cure, or prevent any disease. Learn More
Summary
Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are NAD+ precursors investigated for cellular energy and healthy aging. In adults, early trials show increases in NAD+ biomarkers and suggest potential benefits for fatigue and cardiometabolic markers; cognitive outcomes are exploratory.
Our Picks
NiaCel 400 — Thorne
Supports the vitality of your brain and body with the youthful power of Nicotinamide Riboside. NSF Certified for Sport®.
Mental Clarity, Focus, and Energy
- Energy and fatigue: Some studies report reduced fatigue and improved exercise or daily energy; effects are modest and require consistent use (8–12+ weeks).
- Cognition: Human data are preliminary; any benefits are likely indirect via mitochondrial and vascular pathways.
Brain Health
- Mechanisms: Boost NAD+ pools supporting mitochondrial function, sirtuin signaling, and cellular repair; may influence neurovascular health.
- Human evidence is evolving; large, long‑term cognition trials are limited.
Gut Health
- Generally well tolerated; occasional GI upset or flushing‑like warmth can occur. Take with food if sensitive.
Brain-Gut Axis
- By improving mitochondrial energy and possibly endothelial function, NR/NMN may indirectly support gut–brain communication; direct clinical evidence remains early.
Evidence Summary
Benefit Area | Evidence Quality | Effect Noted | Notes |
Mental Clarity | Emerging | Exploratory cognition signals | Early human data |
Focus Enhancement | Emerging | Small task gains in subsets | Indirect mechanisms |
Energy Support | Moderate | Reduced perceived fatigue | 8–12+ weeks |
Brain Health | Emerging–Moderate | Mitochondrial and vascular pathways | Biomarker increases documented |
Gut Health | Limited | Good tolerance, occasional GI upset | With food if needed |
Brain–Gut Optimization | Emerging | Indirect via energy/vascular effects | Limited direct trials |
Typical Dosing Instructions
- Standard dose: NR 300–600 mg/day or NMN 250–600 mg/day
- Timing: Morning with food to improve tolerance
- Form: Reputable brands; consider third‑party testing
- Notes: Evaluate after 8–12+ weeks; discontinue if no benefit
Safety Considerations
- General safety: Generally well tolerated in short‑to‑mid‑term studies
- Common effects: Mild GI upset, warmth/flushing in some users
- Contraindications and cautions: Limited long‑term safety; potential interactions with chemotherapy and liver‑metabolized drugs
- Populations: Avoid in pregnancy unless clinician‑directed
- Monitoring: Track fatigue, sleep, exercise tolerance, lipids and glucose if relevant; reassess need periodically
References
- Nicotinamide riboside is uniquely and orally bioavailable in mice and humans, increasing NAD+ metabolism in blood, Nature Communications, 2016-10-10
- Chronic nicotinamide riboside supplementation is well‑tolerated and elevates NAD+ in healthy middle‑aged and older adults, Nature Communications, 2018-03-29
- NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR30440-0), Cell Metabolism, 2018-03-06
- Nicotinamide mononucleotide increases insulin sensitivity in prediabetic women, Science, 2021-04-22
- Nicotinamide riboside augments human skeletal muscle NAD+ metabolism and induces transcriptomic signatures linked to mitochondrial biogenesis, The Journal of Physiology, 2019-08-13
- Safety and metabolism of long‑term nicotinamide riboside chloride supplementation in adults, Scientific Reports, 2019-07-05
- Dietary Supplements: What You Need to Know, NIH Office of Dietary Supplements, 2025-09-25